Literature DB >> 11083265

Detection of cerebral involvement in patients with active neuropsychiatric systemic lupus erythematosus by the use of volumetric magnetization transfer imaging.

G P Bosma1, M J Rood, T W Huizinga, B A de Jong, E L Bollen, M A van Buchem.   

Abstract

OBJECTIVE: To determine whether volumetric magnetization transfer imaging (MTI) histogram analysis can detect abnormalities in patients with active neuropsychiatric systemic lupus erythematosus (NPSLE) and to compare the MTI findings in patients with active NPSLE, chronic NPSLE, and multiple sclerosis (MS), as well as in normal control subjects.
METHODS: Eight female and 1 male patient with active nonthromboembolic NPSLE (mean +/- SD age 39 +/- 9 years), 10 female patients with chronic NPSLE (age 33 +/- 11 years), 10 female patients with SLE and no history of NPSLE (non-NPSLE; age 34 +/- 11 years), 10 female patients with inactive MS (age 41 +/- 6 years), and 10 healthy control subjects (age 33 +/- 11 years) underwent MTL. Using the MTI scans, histograms were composed from which we derived a variety of parameters that quantitatively reflect the uniformity of the brain parenchyma as well as the ratio of cerebrospinal fluid to intracranial volume, which reflects atrophy.
RESULTS: The magnetization transfer ratio (MTR) histograms in the non-NPSLE group and the healthy control group were similar, whereas those in the chronic NPSLE and MS groups were flatter. There was also flattening of the histograms in the active NPSLE group, but with a shift toward higher MTRs.
CONCLUSION: Our results indicate that volumetric MTI analysis detects cerebral changes in the active phase of NPSLE. The abnormalities in the brain parenchyma of patients with chronic NPSLE produced MTI values that were the same as those in patients with inactive MS. MTI values in the active phase of NPSLE differed from those in the chronic phase, which might reflect the presence of inflammation. These preliminary results suggest that MTI might provide evidence for the presence of active NPSLE. MTI might also prove to be a valuable technique for monitoring treatment trials.

Entities:  

Mesh:

Year:  2000        PMID: 11083265     DOI: 10.1002/1529-0131(200011)43:11<2428::AID-ANR9>3.0.CO;2-H

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  16 in total

1.  Abnormal brain diffusivity in patients with neuropsychiatric systemic lupus erythematosus.

Authors:  Gerlof P Th Bosma; Tom W J Huizinga; Simon P Mooijaart; Mark A Van Buchem
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

2.  The effect of corticosteroid medication on quantitative MR parameters of the brain.

Authors:  Stefan C A Steens; Gerda M Steup-Beekman; Gerlof P Th Bosma; Faiza Admiraal-Behloul; Hans Olofsen; Joost Doornbos; Tom W J Huizinga; Mark A van Buchem
Journal:  AJNR Am J Neuroradiol       Date:  2005 Nov-Dec       Impact factor: 3.825

3.  Diffusion tensor imaging in neuropsychiatric systemic lupus erythematosus.

Authors:  Rex E Jung; Arvind Caprihan; Robert S Chavez; Ranee A Flores; Janeen Sharrar; Clifford R Qualls; Wilmer Sibbitt; Carlos A Roldan
Journal:  BMC Neurol       Date:  2010-07-28       Impact factor: 2.474

4.  Markers of acute neuropsychiatric systemic lupus erythematosus: a multidisciplinary evaluation.

Authors:  Essam A Abda; Zahraa I Selim; Moustafa E M Radwan; Nagham M Mahmoud; Omar M Herdan; Khalid A Mohamad; Sherifa A Hamed
Journal:  Rheumatol Int       Date:  2012-10-12       Impact factor: 2.631

Review 5.  Neurocognitive impairment in children and adolescents with systemic lupus erythematosus.

Authors:  Deborah M Levy; Stacy P Ardoin; Laura E Schanberg
Journal:  Nat Clin Pract Rheumatol       Date:  2009-02

Review 6.  Magnetization transfer magnetic resonance imaging of the brain, spinal cord, and optic nerve.

Authors:  Massimo Filippi; Maria A Rocca
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

Review 7.  Neuropsychological impairment in systemic lupus erythematosus: a comparison with multiple sclerosis.

Authors:  R H B Benedict; J L Shucard; R Zivadinov; D W Shucard
Journal:  Neuropsychol Rev       Date:  2008-06-03       Impact factor: 7.444

Review 8.  Magnetic resonance imaging in the evaluation of central nervous system manifestations in systemic lupus erythematosus.

Authors:  Simone Appenzeller; G Bruce Pike; Ann E Clarke
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

9.  Sources of variation in multi-centre brain MTR histogram studies: body-coil transmission eliminates inter-centre differences.

Authors:  P S Tofts; S C A Steens; M Cercignani; F Admiraal-Behloul; P A M Hofman; M J P van Osch; W M Teeuwisse; D J Tozer; J H T M van Waesberghe; R Yeung; G J Barker; M A van Buchem
Journal:  MAGMA       Date:  2006-09-07       Impact factor: 2.310

10.  Association between microscopic brain damage as indicated by magnetization transfer imaging and anticardiolipin antibodies in neuropsychiatric lupus.

Authors:  Stefan C A Steens; Gerlof P T H Bosma; Gerda M Steup-Beekman; Saskia le Cessie; Tom W J Huizinga; Mark A van Buchem
Journal:  Arthritis Res Ther       Date:  2006-01-16       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.